866-945-0263 | enquiries@arrowheadpublishers.com

Press Releases

June 16, 2016

 
Genelex CEO Kristine Ashcraft to Share Insights on Future of Pharmacogenomics at 8th Annual Personalized & Precision Medicine Conference

Recently, Genelex responded to requests by various stakeholders in the personalized and precision medicine industry by creating High Risk PGx Drug Charts, which are available on the YouScript software. By providing these helpful resources when interpreting PGx results with these resources, Genelex hopes to improve the evaluation of drug-drug, drug-gene, and cumulative interactions in real-time.

This interactive clinical decision support (CDS) tool analyzes specific patient’s complete drug list and phenotype results, to ensure more predictable patient responses. There are two versions of the chart available through YouScript: one sorted by major drug specialties and the other sorted alphabetically.

As a thought leader in the field of pharmacogenomics, Genelex strives to revolutionize how we can lessen the occurrence of drug side effects. CEO Kristine Ashcraft will be sharing her insights on pharmacogenomics at Arrowhead’s 8th Annual Personalized & Precision Medicine Conference. For more information on the High Risk PGx Drug Charts, visit: http://genelex.com/blog/new-and-improved-high-risk-pgx-drug-charts/.

For more information on the 8th Annual Personalized and Precision Medicine Conference, visit: http://personalizedmedicinepartnerships.com.

Kristine Ashcraft has been a critical part of the leadership team at Genelex since 2000, and has served many roles since then. Ashcraft’s presentation will focus on Genelex’s long-standing commitment to precision medicine and pharmacogenomics, and two critical questions: who do we test, and how do we do it? Included in the High Risk PGx Charts are drug-gene pairs, the worst-case-scenario impact rating for the interaction, and any other available guidelines from a variety of organizations who developed dosing guidelines around the world.

One of the longest running conferences in the personalized and precision medicine space, Arrowhead’s 8th Annual Personalized & Precision Medicine Conference will be held October 12-13, 2016 in the San Francisco Bay Area. With key thought leaders like Kristine Ashcraft presenting on a variety of key themes, attendees will gain valuable insight into the field of precision and personalized medicine.

For more information, contact:

John Waslif: Managing Director

Arrowhead Publishers

866-945-0263

This email address is being protected from spambots. You need JavaScript enabled to view it.

Contact Us

PO Box 96
Chanhassen, MN 55317 USA
866-945-0263
www.arrowheadpublishers.com
enquiries@arrowheadpublishers.com

Speaker Opportunities

If you are interested in speaking at one of Arrowhead's conferences or would like to suggest a conference theme for which you have particular expertise, we'd like to hear from you.

Sponsor/Exhibitor Opportunities

Arrowhead sponsorship and exhibitor levels are designed to give your organization the highest level of exposure and opportunity to market products and branding in an environment that is targeted toward facilitating professional networking. We can also build tailor-made packages that will meet your organization's marketing budget and goals. Arrowhead sponsorships are proven to help grow businesses through direct and targeted exposure to industry leaders and decision makers. To gain critical industry exposure via our sponsorship and exhibiting opportunities, please contact us.